James George Robinson Insider Trading $NYMX NYMOX PHARMACEUTICAL CORP
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for James George Robinson.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of James George Robinson. James George Robinson is Director in NYMOX PHARMACEUTICAL CORP ($NYMX).
James George Robinson in NYMOX PHARMACEUTICAL CORP
Trading Symbol: NYMXIndustry: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
Position of James George Robinson: Director
Holdings: 3,512,550 shares
Current Value: $13,277,439
Latest Transaction: Apr 27 2021
$NYMX Market Capitalization: $174.27M
$NYMX Previous Close: $3.78
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of James George Robinson in NYMOX PHARMACEUTICAL CORP
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Apr 27 2021 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 2.09 | 200 | 417 | 3,550,550 | 3.6 M to 3.6 M (+0.01 %) |
Apr 27 2021 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 2.09 | 1,100 | 2,297 | 3,550,350 | 3.5 M to 3.6 M (+0.03 %) |
Apr 27 2021 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 2.09 | 2,900 | 6,061 | 3,549,250 | 3.5 M to 3.5 M (+0.08 %) |
Apr 27 2021 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 2.10 | 800 | 1,680 | 3,546,350 | 3.5 M to 3.5 M (+0.02 %) |
Apr 27 2021 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 2.08 | 51 | 106 | 3,545,550 | 3.5 M to 3.5 M (0.00 %) |
Apr 27 2021 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 2.09 | 4,949 | 10,343 | 3,545,499 | 3.5 M to 3.5 M (+0.14 %) |
Apr 27 2021 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 2.05 | 5,000 | 10,250 | 3,540,550 | 3.5 M to 3.5 M (+0.14 %) |
Apr 27 2021 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 2.11 | 3,100 | 6,526 | 3,535,550 | 3.5 M to 3.5 M (+0.09 %) |
Apr 27 2021 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 2.13 | 1,900 | 4,047 | 3,532,450 | 3.5 M to 3.5 M (+0.05 %) |
Apr 27 2021 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 2.07 | 7,000 | 14,489 | 3,530,550 | 3.5 M to 3.5 M (+0.20 %) |
Apr 27 2021 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 2.08 | 900 | 1,870 | 3,523,550 | 3.5 M to 3.5 M (+0.03 %) |
Apr 27 2021 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 2.08 | 4,100 | 8,528 | 3,522,650 | 3.5 M to 3.5 M (+0.12 %) |
Apr 27 2021 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 2.08 | 6,000 | 12,480 | 3,518,550 | 3.5 M to 3.5 M (+0.17 %) |
Apr 27 2021 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 2.09 | 2,000 | 4,180 | 3,512,550 | 3.5 M to 3.5 M (+0.06 %) |
Jul 12 2019 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 1.72 | 100 | 172 | 3,510,550 | 3.5 M to 3.5 M (0.00 %) |
Jul 12 2019 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 1.73 | 166 | 287 | 3,510,450 | 3.5 M to 3.5 M (0.00 %) |
Jul 12 2019 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 1.72 | 600 | 1,033 | 3,510,284 | 3.5 M to 3.5 M (+0.02 %) |
Jul 12 2019 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 1.73 | 300 | 519 | 3,509,684 | 3.5 M to 3.5 M (+0.01 %) |
Jul 12 2019 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 1.73 | 5,834 | 10,093 | 3,509,384 | 3.5 M to 3.5 M (+0.17 %) |
Jul 10 2019 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 1.63 | 7,000 | 11,400 | 3,503,550 | 3.5 M to 3.5 M (+0.20 %) |
Jul 09 2019 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 1.45 | 9,000 | 13,049 | 3,496,550 | 3.5 M to 3.5 M (+0.26 %) |
Jul 03 2019 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 1.54 | 8,000 | 12,354 | 3,487,550 | 3.5 M to 3.5 M (+0.23 %) |
Jul 02 2019 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 1.36 | 400 | 545 | 3,479,550 | 3.5 M to 3.5 M (+0.01 %) |
Jul 02 2019 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 1.36 | 371 | 505 | 3,479,150 | 3.5 M to 3.5 M (+0.01 %) |
Jul 02 2019 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 1.37 | 100 | 137 | 3,478,779 | 3.5 M to 3.5 M (0.00 %) |
Jul 02 2019 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 1.37 | 28 | 38 | 3,478,679 | 3.5 M to 3.5 M (0.00 %) |
Jul 02 2019 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 1.37 | 295 | 404 | 3,478,651 | 3.5 M to 3.5 M (+0.01 %) |
Jul 02 2019 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 1.36 | 800 | 1,090 | 3,478,356 | 3.5 M to 3.5 M (+0.02 %) |
Jul 02 2019 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 1.37 | 4,806 | 6,584 | 3,477,556 | 3.5 M to 3.5 M (+0.14 %) |
Jul 02 2019 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 1.37 | 2,200 | 3,003 | 3,472,750 | 3.5 M to 3.5 M (+0.06 %) |
Jul 01 2019 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 1.48 | 800 | 1,183 | 3,470,550 | 3.5 M to 3.5 M (+0.02 %) |
Jul 01 2019 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 1.48 | 3,015 | 4,462 | 3,469,750 | 3.5 M to 3.5 M (+0.09 %) |
Jul 01 2019 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 1.49 | 1,000 | 1,490 | 3,466,735 | 3.5 M to 3.5 M (+0.03 %) |
Jul 01 2019 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 150.00 | 920 | 138,000 | 3,465,735 | 3.5 M to 3.5 M (+0.03 %) |
Jul 01 2019 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 1.52 | 3,155 | 4,796 | 3,464,815 | 3.5 M to 3.5 M (+0.09 %) |
Jul 01 2019 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 1.48 | 1,110 | 1,637 | 3,461,660 | 3.5 M to 3.5 M (+0.03 %) |
Jun 28 2019 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 1.54 | 527 | 813 | 3,460,550 | 3.5 M to 3.5 M (+0.02 %) |
Jun 28 2019 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 1.55 | 473 | 734 | 3,460,023 | 3.5 M to 3.5 M (+0.01 %) |
Jun 28 2019 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 1.56 | 6,235 | 9,727 | 3,459,550 | 3.5 M to 3.5 M (+0.18 %) |
Jun 28 2019 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 1.56 | 32 | 50 | 3,453,315 | 3.5 M to 3.5 M (0.00 %) |
Jun 28 2019 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 1.56 | 1,733 | 2,700 | 3,453,283 | 3.5 M to 3.5 M (+0.05 %) |
Jun 27 2019 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 1.71 | 8,000 | 13,680 | 3,451,550 | 3.4 M to 3.5 M (+0.23 %) |
Jun 26 2019 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 1.73 | 1,400 | 2,422 | 3,443,550 | 3.4 M to 3.4 M (+0.04 %) |
Jun 26 2019 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 1.73 | 200 | 346 | 3,442,150 | 3.4 M to 3.4 M (+0.01 %) |
Jun 26 2019 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 1.73 | 7,400 | 12,765 | 3,441,950 | 3.4 M to 3.4 M (+0.22 %) |
Jun 21 2019 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 1.77 | 9,000 | 15,918 | 3,434,550 | 3.4 M to 3.4 M (+0.26 %) |
Jun 20 2019 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 1.69 | 8,000 | 13,529 | 3,425,550 | 3.4 M to 3.4 M (+0.23 %) |
Jun 19 2019 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 1.67 | 8,900 | 14,881 | 3,417,550 | 3.4 M to 3.4 M (+0.26 %) |
Jun 19 2019 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 1.65 | 100 | 165 | 3,408,650 | 3.4 M to 3.4 M (0.00 %) |
Jun 18 2019 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 1.42 | 8,000 | 11,344 | 3,408,550 | 3.4 M to 3.4 M (+0.24 %) |
Jun 12 2019 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 1.60 | 287 | 459 | 3,400,550 | 3.4 M to 3.4 M (+0.01 %) |
Jun 12 2019 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 1.54 | 300 | 462 | 3,400,263 | 3.4 M to 3.4 M (+0.01 %) |
Jun 12 2019 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 1.53 | 200 | 306 | 3,399,963 | 3.4 M to 3.4 M (+0.01 %) |
Jun 12 2019 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 1.52 | 400 | 608 | 3,399,763 | 3.4 M to 3.4 M (+0.01 %) |
Jun 12 2019 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 1.51 | 701 | 1,059 | 3,399,363 | 3.4 M to 3.4 M (+0.02 %) |
Jun 12 2019 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 1.49 | 500 | 745 | 3,398,662 | 3.4 M to 3.4 M (+0.01 %) |
Jun 12 2019 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 1.48 | 900 | 1,332 | 3,398,162 | 3.4 M to 3.4 M (+0.03 %) |
Jun 12 2019 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 1.47 | 100 | 147 | 3,397,262 | 3.4 M to 3.4 M (0.00 %) |
Jun 12 2019 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 1.45 | 1,300 | 1,885 | 3,397,162 | 3.4 M to 3.4 M (+0.04 %) |
Jun 12 2019 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 1.44 | 1,100 | 1,584 | 3,395,862 | 3.4 M to 3.4 M (+0.03 %) |
Jun 12 2019 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 1.43 | 700 | 1,001 | 3,394,762 | 3.4 M to 3.4 M (+0.02 %) |
Jun 12 2019 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 1.42 | 200 | 284 | 3,394,062 | 3.4 M to 3.4 M (+0.01 %) |
Jun 12 2019 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 1.42 | 1,430 | 2,029 | 3,393,862 | 3.4 M to 3.4 M (+0.04 %) |
Jun 12 2019 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 1.42 | 882 | 1,248 | 3,392,432 | 3.4 M to 3.4 M (+0.03 %) |
Jun 12 2019 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 1.54 | 8,000 | 12,288 | 3,391,550 | 3.4 M to 3.4 M (+0.24 %) |
Jun 07 2019 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 1.59 | 5,201 | 8,270 | 3,383,550 | 3.4 M to 3.4 M (+0.15 %) |
Jun 07 2019 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 1.58 | 100 | 158 | 3,378,349 | 3.4 M to 3.4 M (0.00 %) |
Jun 07 2019 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 1.56 | 600 | 936 | 3,378,249 | 3.4 M to 3.4 M (+0.02 %) |
Jun 07 2019 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 1.55 | 800 | 1,240 | 3,377,649 | 3.4 M to 3.4 M (+0.02 %) |
Jun 07 2019 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 1.54 | 799 | 1,230 | 3,376,849 | 3.4 M to 3.4 M (+0.02 %) |
Jun 07 2019 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 1.53 | 1,100 | 1,683 | 3,376,050 | 3.4 M to 3.4 M (+0.03 %) |
Jun 07 2019 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 1.53 | 400 | 611 | 3,374,950 | 3.4 M to 3.4 M (+0.01 %) |
Jun 07 2019 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 1.52 | 1,000 | 1,520 | 3,374,550 | 3.4 M to 3.4 M (+0.03 %) |
Jun 06 2019 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 1.56 | 7,537 | 11,758 | 3,373,550 | 3.4 M to 3.4 M (+0.22 %) |
Jun 06 2019 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 1.55 | 1,000 | 1,550 | 3,366,013 | 3.4 M to 3.4 M (+0.03 %) |
Jun 06 2019 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 1.54 | 1,863 | 2,869 | 3,365,013 | 3.4 M to 3.4 M (+0.06 %) |
Jun 06 2019 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 1.53 | 400 | 611 | 3,363,150 | 3.4 M to 3.4 M (+0.01 %) |
Jun 06 2019 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 1.53 | 200 | 305 | 3,362,750 | 3.4 M to 3.4 M (+0.01 %) |
Jun 04 2019 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 1.62 | 9,000 | 14,598 | 3,362,550 | 3.4 M to 3.4 M (+0.27 %) |
Jun 04 2019 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 1.61 | 1,093 | 1,760 | 3,353,550 | 3.4 M to 3.4 M (+0.03 %) |
Jun 04 2019 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 1.60 | 300 | 480 | 3,352,457 | 3.4 M to 3.4 M (+0.01 %) |
Jun 04 2019 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 1.59 | 8,600 | 13,674 | 3,352,157 | 3.3 M to 3.4 M (+0.26 %) |
Jun 04 2019 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 1.58 | 7 | 11 | 3,343,557 | 3.3 M to 3.3 M (0.00 %) |
May 31 2019 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 1.76 | 7,700 | 13,553 | 3,343,550 | 3.3 M to 3.3 M (+0.23 %) |
May 31 2019 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 1.77 | 100 | 177 | 3,335,850 | 3.3 M to 3.3 M (0.00 %) |
May 31 2019 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 1.77 | 600 | 1,061 | 3,335,750 | 3.3 M to 3.3 M (+0.02 %) |
May 31 2019 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 1.77 | 100 | 177 | 3,335,150 | 3.3 M to 3.3 M (0.00 %) |
May 30 2019 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 1.68 | 9,000 | 15,098 | 3,335,050 | 3.3 M to 3.3 M (+0.27 %) |
May 28 2019 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 1.59 | 8,000 | 12,750 | 3,326,050 | 3.3 M to 3.3 M (+0.24 %) |
May 28 2019 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 1.55 | 7,500 | 11,657 | 3,318,050 | 3.3 M to 3.3 M (+0.23 %) |
Dec 14 2018 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 1.72 | 5,237 | 9,007 | 3,310,550 | 3.3 M to 3.3 M (+0.16 %) |
Dec 13 2018 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 1.71 | 6,000 | 10,285 | 3,305,313 | 3.3 M to 3.3 M (+0.18 %) |
Dec 12 2018 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 1.67 | 5,000 | 8,359 | 3,299,313 | 3.3 M to 3.3 M (+0.15 %) |
Dec 11 2018 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 1.62 | 7,500 | 12,132 | 3,294,313 | 3.3 M to 3.3 M (+0.23 %) |
Dec 10 2018 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 1.69 | 7,000 | 11,821 | 3,286,813 | 3.3 M to 3.3 M (+0.21 %) |
Dec 07 2018 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 1.74 | 1,400 | 2,436 | 3,279,813 | 3.3 M to 3.3 M (+0.04 %) |
Dec 06 2018 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 1.72 | 7,500 | 12,899 | 3,278,413 | 3.3 M to 3.3 M (+0.23 %) |
Dec 03 2018 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 1.84 | 5,000 | 9,200 | 3,270,913 | 3.3 M to 3.3 M (+0.15 %) |
Dec 03 2018 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 1.84 | 5,000 | 9,200 | 3,270,913 | 3.3 M to 3.3 M (+0.15 %) |
Nov 30 2018 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 1.81 | 7,000 | 12,660 | 3,265,913 | 3.3 M to 3.3 M (+0.21 %) |
Nov 28 2018 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 1.71 | 8,000 | 13,679 | 3,258,913 | 3.3 M to 3.3 M (+0.25 %) |
Nov 21 2018 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 1.78 | 6,000 | 10,706 | 3,250,913 | 3.2 M to 3.3 M (+0.18 %) |
Nov 21 2018 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 1.74 | 9,000 | 15,675 | 3,244,913 | 3.2 M to 3.2 M (+0.28 %) |
Nov 21 2018 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 1.93 | 6,000 | 11,580 | 3,235,913 | 3.2 M to 3.2 M (+0.19 %) |
Nov 15 2018 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 2.00 | 7,000 | 13,994 | 3,229,913 | 3.2 M to 3.2 M (+0.22 %) |
Nov 13 2018 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 2.14 | 700 | 1,495 | 3,222,913 | 3.2 M to 3.2 M (+0.02 %) |
Nov 13 2018 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 2.12 | 6,300 | 13,374 | 3,222,213 | 3.2 M to 3.2 M (+0.20 %) |
Nov 13 2018 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 2.06 | 5,573 | 11,479 | 3,215,913 | 3.2 M to 3.2 M (+0.17 %) |
Nov 13 2018 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 2.06 | 100 | 206 | 3,210,340 | 3.2 M to 3.2 M (0.00 %) |
Nov 13 2018 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 2.05 | 327 | 670 | 3,210,240 | 3.2 M to 3.2 M (+0.01 %) |
Nov 09 2018 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 2.04 | 363 | 740 | 3,209,913 | 3.2 M to 3.2 M (+0.01 %) |
Nov 06 2018 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 1.98 | 1,050 | 2,079 | 3,209,550 | 3.2 M to 3.2 M (+0.03 %) |
Nov 06 2018 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 1.98 | 4,150 | 8,217 | 3,208,500 | 3.2 M to 3.2 M (+0.13 %) |
Nov 06 2018 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 1.97 | 1,800 | 3,546 | 3,204,350 | 3.2 M to 3.2 M (+0.06 %) |
Nov 02 2018 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 1.90 | 6,000 | 11,400 | 3,202,550 | 3.2 M to 3.2 M (+0.19 %) |
Nov 02 2018 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 1.90 | 6,000 | 11,400 | 3,202,550 | 3.2 M to 3.2 M (+0.19 %) |
Nov 01 2018 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 1.79 | 6,000 | 10,733 | 3,196,550 | 3.2 M to 3.2 M (+0.19 %) |
Nov 01 2018 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 1.79 | 6,000 | 10,766 | 3,190,550 | 3.2 M to 3.2 M (+0.19 %) |
Nov 01 2018 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 1.78 | 6,000 | 10,665 | 3,184,550 | 3.2 M to 3.2 M (+0.19 %) |
Oct 26 2018 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 1.63 | 6,700 | 10,921 | 3,178,550 | 3.2 M to 3.2 M (+0.21 %) |
Oct 26 2018 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 1.63 | 6,700 | 10,921 | 3,178,550 | 3.2 M to 3.2 M (+0.21 %) |
Oct 26 2018 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 1.62 | 700 | 1,134 | 3,171,850 | 3.2 M to 3.2 M (+0.02 %) |
Oct 26 2018 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 1.62 | 700 | 1,134 | 3,171,850 | 3.2 M to 3.2 M (+0.02 %) |
Oct 26 2018 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 1.61 | 1,090 | 1,755 | 3,171,150 | 3.2 M to 3.2 M (+0.03 %) |
Oct 26 2018 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 1.61 | 1,090 | 1,755 | 3,171,150 | 3.2 M to 3.2 M (+0.03 %) |
Oct 26 2018 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 1.61 | 600 | 963 | 3,170,060 | 3.2 M to 3.2 M (+0.02 %) |
Oct 26 2018 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 1.61 | 600 | 963 | 3,170,060 | 3.2 M to 3.2 M (+0.02 %) |
Oct 26 2018 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 1.60 | 510 | 816 | 3,169,460 | 3.2 M to 3.2 M (+0.02 %) |
Oct 26 2018 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 1.60 | 510 | 816 | 3,169,460 | 3.2 M to 3.2 M (+0.02 %) |
Oct 26 2018 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 1.59 | 400 | 636 | 3,168,950 | 3.2 M to 3.2 M (+0.01 %) |
Oct 26 2018 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 1.59 | 400 | 636 | 3,168,950 | 3.2 M to 3.2 M (+0.01 %) |
Oct 25 2018 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 1.67 | 8,000 | 13,340 | 3,168,550 | 3.2 M to 3.2 M (+0.25 %) |
Oct 25 2018 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 1.67 | 8,000 | 13,340 | 13,340 | 5.3 K to 13.3 K (+149.81 %) |
Mar 27 2018 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 3.94 | 100 | 394 | 3,160,550 | 3.2 M to 3.2 M (0.00 %) |
Mar 27 2018 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 3.93 | 900 | 3,537 | 3,160,450 | 3.2 M to 3.2 M (+0.03 %) |
Mar 27 2018 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 3.93 | 7,000 | 27,503 | 3,159,550 | 3.2 M to 3.2 M (+0.22 %) |
Mar 22 2018 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 4.02 | 8,000 | 32,160 | 3,152,550 | 3.1 M to 3.2 M (+0.25 %) |
Mar 16 2018 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 3.58 | 8,000 | 28,672 | 3,144,550 | 3.1 M to 3.1 M (+0.26 %) |
Mar 12 2018 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 3.48 | 8,000 | 27,864 | 3,136,550 | 3.1 M to 3.1 M (+0.26 %) |
Feb 23 2018 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 3.23 | 5,300 | 17,119 | 3,128,550 | 3.1 M to 3.1 M (+0.17 %) |
Feb 23 2018 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 3.22 | 700 | 2,254 | 3,123,250 | 3.1 M to 3.1 M (+0.02 %) |
Feb 23 2018 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 3.23 | 5,300 | 17,119 | 3,128,550 | 3.1 M to 3.1 M (+0.17 %) |
Feb 23 2018 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 3.22 | 700 | 2,254 | 3,123,250 | 3.1 M to 3.1 M (+0.02 %) |
Feb 20 2018 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 3.27 | 3,941 | 12,895 | 3,122,550 | 3.1 M to 3.1 M (+0.13 %) |
Feb 20 2018 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 3.28 | 3,059 | 10,026 | 3,118,609 | 3.1 M to 3.1 M (+0.10 %) |
Feb 13 2018 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 3.33 | 1,000 | 3,330 | 3,115,550 | 3.1 M to 3.1 M (+0.03 %) |
Feb 13 2018 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 3.32 | 500 | 1,660 | 3,114,550 | 3.1 M to 3.1 M (+0.02 %) |
Feb 13 2018 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 3.31 | 100 | 331 | 3,114,050 | 3.1 M to 3.1 M (0.00 %) |
Feb 13 2018 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 3.30 | 200 | 660 | 3,113,950 | 3.1 M to 3.1 M (+0.01 %) |
Feb 13 2018 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 3.29 | 100 | 329 | 3,113,750 | 3.1 M to 3.1 M (0.00 %) |